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Introduction
Endoscopic retrograde cholangiopancreatography (ERCP)
has become a commonplace gastroenterological procedure,
but post-ERCP acute pancreatitis remains an appreciable
source of morbidity. Studies have documented an incidence
of pancreatitis between 1 and 5% after diagnostic ERCP
and up to 15% after therapeutic ERCP [1–7], although we
have previously demonstrated little difference in com-
plications between diagnostic and therapeutic ERCP [8]. A
better understanding of the risk factors associated with
this complication might provide insight into its cause and
suggest strategies for its prevention.
Several variables have already been linked to an
increased risk of developing post-ERCP pancreatitis. These
are younger age [6], difficulty with cannulation [6,8], pres-
ence of (or suspected) sphincter of Oddi dysfunction [4,6],
number of contrast injections [1,6,9], acinarisation during
injection of contrast [1,6], performance of a pancreatogram
[2,8,9], performance of sphincterotomy [6,8] and prior his-
tory of post-ERCP pancreatitis [6,8]. Prior history of pan-
creatitis may, however, correlate inversely with severity of
post-ERCP pancreatitis [5]. The use of low osmolar, non-
ionic contrast media does not decrease the risk for post-
ERCP pancreatitis [10].
Hypotension associated with cardiopulmonary bypass
has been shown to cause acute pancreatitis, but it is an
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Background
In patients undergoing cardiopulmonary bypass, hypoten-
sion is a risk factor for developing acute pancreatitis .
Hypotension in animal models can also induce pancreatitis .
We sought to determine whether or not relative hypoten-
sion during ERCP is a risk factor for developing acute
pancreatitis.
Patients and methods
A nested, case-control study reviewed all cases of post-
ERCP pancreatitis resulting from ERCPs performed at this
institution between May 1993 and May 1998. Post-ERCP
pancreatitis was defined as abdominal pain requiring hospi-
talisation and elevation of serum amylase or lipase more
than four times the upper limit of normal 24 hours or more
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ERCP. Hypotension was defined as any systolic blood pres-
sure (SBP) ,100 mmHg, diastolic blood pressure (DBP)
,60 mmHg, or mean blood pressure (MBP) ,80 mmHg.
Controls were chosen randomly from ERCPs performed
on the same or the nearest day as each index case.
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an incidence of 5.2%. The average age of cases was 48
years, while that of controls was 55 years (p,0.003).There
were no differences between the groups regarding gender,
ERCP findings, need for sphincterotomy nor acinar filling
on the pancreatogram (acinarisation).At least one episode
of hypotension was recorded in 32% of cases and 30% of
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uncommon complication occurring in only 0.1–7.7% of
such operations [11–17]. The aetiology of pancreatitis in
these situations is unknown, but pancreatic ischaemia may
be a factor. In animal models, hypotension induced by
haemorrhage can result in acute pancreatitis [18].
Hypotension results in diminished blood flow within the
pancreatic microvasculature and subsequent tissue
ischaemia [18,19]. We sought to determine whether or not
hypotension during ERCP is associated with an increased
risk of developing subsequent pancreatitis.
Patients and methods
Patients
All cases of post-ERCP acute pancreatitis resulting from
ERCP performed at our institution between May 1993 and
May 1998 were included in this study. Demographic, clinical,
and procedural data about each case were prospectively
recorded in our endoscopy centre database. Information
recorded included age, gender, indication for procedure,
findings during the procedure, types and quantity of seda-
tion used, presence or absence of acinarisation during injec-
tion of contrast into the pancreatic duct, performance of
sphincterotomy and many other variables. Post-ERCP pan-
creatitis was defined as abdominal pain requiring hospitali-
sation and elevation of serum amylase or lipase more than
four times the upper limit of normal 24 hours or more after
ERCP. Severity of pancreatitis was determined according to
a modified grading scale previously defined [3]. Patient fol-
low-up was performed prospectively and captured cases of
pancreatitis admitted to our own and other hospitals.
Patient follow-up was maintained by subsequent office vis-
its, telephone conversations with patients, and by written
or verbal communication with referring physicians.
Admissions to outside facilities were also documented in
this fashion. Controls were chosen randomly from ERCPs
performed on the same or the nearest day as each index case.
Haemodynamic monitoring
Non-invasive blood pressure measurements were recorded
automatically during ERCP using an Accutor Plus
(Datascope Corp., Paramus, NJ). Measurements were taken
at least every 5 min in accordance with our institutional
policy for conscious sedation. Printouts containing every
recorded systolic blood pressure (SBP), diastolic blood pres-
sure (DBP), mean blood pressure (MBP), pulse rate and
oxygen saturation were included with the endoscopy report
in each patient’s medical record. Haemodynamic monitor-
ing typically began several minutes before administration of
sedation. Measurements were taken regularly throughout
the procedure and continued for several minutes after with-
drawal of the endoscope. There are no uniformly accepted
blood pressure values that define hypotension. For the pur-
poses of this study we were mainly interested in comparing
values between the cases and controls. Based on clinical
experience, we chose to define hypotension as any
SBP,100 mmHg, DBP,60 mmHg, or MBP,80 mmHg.
MBP is calculated by the Accutor Plus according to the
formula:
SBP12(DBP)
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Statistical analysis
Mean pre-procedure and intra-procedure SBP, DBP and
MBP were calculated for both cases and controls. Mean
lowest procedure SBP, DBP and MBP were also calculated
for both cases and controls. To determine whether relative
declines in blood pressure were a risk for pancreatitis, the
mean differences between pre-procedure and lowest proce-
dure SBP, DBP and MBPs were calculated for both cases
and controls. Continuous variables were analysed using
Student’s t-test and categorical variables were compared
using chi-square analysis or the Fisher’s exact test when
indicated.
Results
From 1854 ERCPs recorded in our database for the period
reviewed, there were 96 cases of post-ERCP pancreatitis for
an incidence of 5.2%.
Patient characteristics
Demographic and procedural information was available for
all patients studied. Patient characteristics are shown in
Table 1. The average age of cases was 48 years, while that
of controls was 55 years (p,0.003). There were no differ-
ences between the groups regarding gender, ERCP findings,
need for sphincterotomy, nor acinarisation. A prior history
of post-ERCP pancreatitis carried a significant risk for
developing post-ERCP pancreatitis with an odds ratio of
4.0 (95% CI 1.52–10.94). However, a prior history of pan-
creatitis not related to ERCP did not carry an increased risk
for developing post-ERCP pancreatitis (O.R. 1.5, 95% 
CI . 79–2.68).
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The severity of post-ERCP pancreatitis was mild in 73%
of cases, moderate in 23% of cases and severe in 4% of
cases. There were no deaths resulting from post-ERCP pan-
creatitis in this study.
Haemodynamic measurements
Haemodynamic measurements were available for 97%
of both cases and controls. At least one episode of hypoten-
sion was recorded in 32% of cases and 30% of controls
(p50.75). This same incidence of hypotension was
observed at each level of severity of pancreatitis. Most
episodes of hypotension lasted less than 10 min. Only one
patient experienced prolonged hypotension, this being a
control patient who had a MBP below 70 mmHg for 50
min. Episodes of hypotension were either treated with
intravenous fluid or were simply documented. No patient
received pressor support. There were no adverse sequelae
that could be attributed to hypotensive episodes.
Comparison of haemodynamic measurements between
cases and controls is shown in Table 2. There were no
differences between cases and controls comparing mean
pre- and intra-procedure SBP, DBP and MBPs or lowest
procedure SBP, DBP and MBP. Likewise, the mean decline
from pre-procedure measurements to lowest procedure
measurements was the same between cases and controls.
Since our definition of hypotension may have been too
restrictive to detect a difference between cases and con-
trols, we lowered our threshold value for hypotension as a
categorical variable to any SBP,90 mmHg, DBP,50
mmHg, or MBP,70 mmHg. Using these values, at least
one episode of acute hypotension was observed in 15% of
cases and 13% of controls.
Medication usage and hypotension
The total amount of medication used during ERCP did not
differ between normotensive patients and those who expe-
rienced hypotensive episodes. This statement held true for
midazolam, meperidine, fentanyl and glucagon. However,
when we examined the timing of hypotensive episodes,
41% occurred within 5 min after administration of either a
sedative or glucagon. All medications were associated with
at least one episode of hypotension without any particular
drug emerging as especially noxious.
Discussion
In this study, we examined the role of relative hypotension
during ERCP as a risk factor for post-ERCP pancreatitis.
Our incidence of post-ERCP pancreatitis was found to be
5.2% and is consistent with values reported previously in
the literature [3–6]. Younger age was found to be a statisti-
cally significant risk factor for developing pancreatitis. This
finding has been demonstrated in the past [6] with similar
age differences. While these mean ages are statistically dif-
ferent, the clinical relevance of the age difference remains
unclear. Also demonstrated in this study was an increased
risk of post-ERCP pancreatitis in patients with a prior his-
tory of this complication.
Regarding haemodynamic measurements, we found that
brief episodes of acute hypotension are common during
ERCP, occurring during one-third of procedures. Over half
of these episodes do not appear related to the administra-
tion of sedatives or glucagon. However, hypotension was
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Table 1. Patient characteristics
Cases Controls pValue
Number 96 96
Mean age (years) 48 55 0.003
Male/female 35/61 32/64 NS
ERCP findings (%)
Normal 21.9 19.8 NS
CBD stones 11.5 18.8 NS
Malignant stricture 12.5 12.5 NS
Chronic pancreatitis 10.4 8.3 NS
Pancreas divisum 6.2 5.2 NS
Sphincter of Oddi dysfunction 7.3 2.1 NS*
Other 30.2 33.3 NS
Biliary sphincterotomy 17 (17.7%) 13 (13.5%) NS
Acinarisation 5 (5.2%) 8 (8.3%) NS
*Fisher’s exact test
Table 2. Haemodynamic measurements*
Cases Controls
% SBP,100 mmHg
** 17.2 18.3
% DBP,60 mm Hg
** 23.7 23.7
% MBP,80 mmHg
** 28 28
Mean pre-procedure SBP*** 131620.0 136620.0
Mean pre-procedure DBP 81614.2 81611.1
Mean pre-procedure MBP 100615.7 102613.6
Mean intra-procedure SBP 142619.4 144621.1
Mean intra-procedure DBP 84611.8 84610.2
Mean intra-procedure MBP 106618.6 108614.0
Mean lowest procedure SBP 119622.3 120622.3
Mean lowest procedure DBP 68614.7 68612.2
Mean loweset procedure MBP 89617.2 89615.7
*None of the differences is statistically significant
**Per cent of cases or controls in which at least one blood pressure read-
ing fell below the cutoff
***Standard deviation
SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean
blood pressure
not associated with the development of acute pancreatitis
or any other adverse sequelae. This finding differs from the
published experience following cardiopulmonary bypass
and aortic cross-clamping. Fernandez-del Castillo and col-
leagues prospectively examined 300 patients for pancreatic
cellular injury after cardiopulmonary bypass [15]. Eighty
patients (27%) demonstrated evidence of pancreatic injury
defined as elevated serum levels of amylase and either pan-
creatic isoamylase or lipase (or both). Of these 80 patients,
23 experienced signs or symptoms potentially attributable
to pancreatitis, giving an overall incidence of 7.7%.
Postoperative hypotension, defined as a MBP,80 mmHg,
was noted in 35% of patients experiencing pancreatic cel-
lular injury compared with 7% of patients without injury
(p,0.0001). Exogenous calcium was also shown to be a risk
factor for ‘post-pump’ pancreatitis. These investigators
have subsequently shown that, while hypotension alone
causes pancreatitis in rats, the subsequent administration of
calcium chloride augments the effects of hypotension and
results in a more severe form of organ damage [20].
Christenson and co-workers identified 86 gastrointesti-
nal complications following 3493 cardiac operations [17].
Nine patients (10% of complications) developed acute
pancreatitis. In their analysis of variables associated with
complications, low postoperative cardiac output emerged as
a major risk factor. The authors concluded that splanchnic
hypoperfusion and visceral ischaemia represent a common
aetiology for the development of gastrointestinal complica-
tions, including pancreatitis.
Taking pancreatic hypoperfusion a step further, Gullo
and associates [21] characterised the level of pancreatic
injury following cross-clamping of the aorta in patients
undergoing operation for thoracic or thoracoabdominal aor-
tic aneurysms. Serum levels of amylase, pancreatic isoamy-
lase and lipase were monitored in the perioperative setting.
Patients were also assessed postoperatively for clinical evi-
dence of acute pancreatitis. The mean length of cross-clamp
time was 44 min. Only one out of the 21 patients studied
developed clinically evident pancreatitis: this was a fatal
case of necrotising pancreatitis in a woman who had her
aorta cross-clamped for 43 min. The remaining patients uni-
formly demonstrated elevations in serum pancreatic enzyme
levels shortly after declamping. A correlation was seen
between the duration of cross-clamping and the level of pan-
creatic enzyme release. This study provides evidence that
ischaemia can cause acute pancreatitis, although the sever-
ity of ischaemia with cross-clamping of the aorta would pre-
sumably be much greater than that from minor hypoper-
fusion. Ischaemia has also been cited as the cause of pan-
creatitis in the setting of shock [22], emboli [23,24],
transplantation of the pancreas [25], ergotamine poison-
ing [26] and polyartertitis nodosa [27]. In rats, splanchnic
vasoconstriction secondary to phenylephrine can worsen
the severity of otherwise mild pancreatitis [28]. This
effect can be mitigated by using alpha-adrenergic receptor
blockade, which improves splanchnic blood flow. The
pathogenesis of ischaemic pancreatitis is suspected to
include reperfusion injury and local production of oxygen
free radicals [29–33].
In this study we failed to find an association between
hypotension and post-ERCP pancreatitis. The study may be
limited by the number of cases available for consideration.
We acknowledge that the incidence of hypotension-associ-
ated pancreatitis is very low. However, the cause of post-
ERCP pancreatitis is multifactorial. Our concern was that
the insult of hypotension during ERCP might be synergis-
tic with the well-established risks conferred by manipula-
tion of the pancreas or papilla.
Another limitation is the duration of hypotension asso-
ciated with ERCP. Most episodes of hypotension lasted less
than 10 min. It is possible that more prolonged hypotensive
episodes would have resulted in more cases of post-ERCP
pancreatitis. In addition, because the automated blood
pressure monitoring occurred at 5-min intervals, transient
episodes of hypotension lasting less than 5 min may have
been missed. It is quite possible therefore that the true inci-
dence of hypotension during ERCP is higher than the rate
that we observed in this study.
The use of non-invasive blood pressure monitoring rais-
es certain concerns. Spurious results may arise from patient
movement or changes in position. Review of the individ-
ual records allowed us to verify that drops in blood
pressure were (1) accompanied by compensatory increases
in heart rate, (2) accompanied by a coincident decrease in
heart rate consistent with increased vagal tone, or (3) ver-
ified by repeat measurements taken in a timely manner.
After reviewing the haemodynamic records, nine cases
and six controls had hypotensive episodes that may have
been spurious. Excluding these cases would lower the
overall incidence of hypotension during ERCP to 22%
from 30%.
In conclusion, there was quite a high incidence of
acute, self-limited hypotension during ERCP. Unlike the
situation with cardiopulmonary bypass or cross-clamping of
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the aorta, hypotension during ERCP does not appear to be
associated with post-procedure pancreatitis.
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